HDL cholesterol: "The next frontier for atherosclerosis management"

November 6, 2006

As patents for statins expire, drug companies are looking at the next blockbusters to raise HDL. The data is still pending on whether raising HDL lowers mortality:

Doctors also know people who have too-high LDL but never succumb to cardiac trouble – perhaps, in some cases, because their high HDL is protecting them.

The interest in HDL cholesterol is also, to some extent, market-driven. Many drug companies have blockbuster statin drugs with patents that are expiring, and they’re searching for ways to reignite the market for treating cardiovascular disease.

In this case, however, market forces and the quest for better heart health may happily align.



Related posts:

  1. The mirage of HDL cholesterol
  2. Why you should stop taking Vytorin for high cholesterol
  3. Movies and Big Pharma
  4. Gram negative superbugs
  5. Diagnosis to chronic disease management
  6. Kids on statins?
  7. Brewer: Falling HDLs due to generic statins?


KevinMD.com on Facebook


  Follow on Twitter   Subscribe



{ 1 comment }

1 Anonymous November 6, 2006 at 4:49 pm

Question for cholesterol gurus: I am 45, have a strong family hx heart disease. My total cholesterol is low 100-130’s when I have had it checked. My will be 29-33. I am an exercise addict. Anyone have a comment how much of a risk that low hdl is???

Comments on this entry are closed.

Previous post: More physicians need to be involved in health policy decisions

Next post: The ten most harmful health gadgets

Site Meter